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Abstract During the last few decades more and
more attention has been paid to triterpenes—a group
of compounds with five- or four-ring skeleton and
carboxyl, hydroxyl or oxo groups. Triterpenes with
unsubstituted C-3 hydroxyl group can be easily
transformed into appropriate ketones and then into
oximes. The carbonyl group can be created not only
from the hydroxyl group at C-3 position, but also at
C-2, C-12 or C-28 positions. Several methods of
creation of two = NOH groups within one molecule
of triterpene are known. There are also known
triterpenes with two carbonyl groups, e.g. at C-3 and
C-11 positions, which differ in reactivity: among them
only C-3 group can be transformed into oxime. A
reactive hydroxyimine group can undergo the action
of acylating agents, such as carboxylic acids or their
derivatives, also the ones with significant pharmaco-
logical activity. Acyl derivatives of triterpenic oximes
exhibit important pharmacological activity. The bio-
logical tests performed with the use of cell cultures
inoculated with viruses showed inhibitory activity of
some triterpenic acyloximes against type 1 HSV
(H7N1), ECHO-6 and HIV-1 viruses. Another acyl-
ated oximes derived from triterpenes shown cytotoxic
or antiproliferative activity against many lines of
cancer cells. In many cases the pharmacological
effects of the tested acyloxyiminotriterpenes were
comparable to those of appropriate standard drugs.
One of the newest application of acyl derivatives of
triterpenic oximes is their ability to form organogels.
Keywords Acyl derivatives of triterpenic
oximes  Derivatives of triterpenes  Triterpenes 
Triterpenic oximes
Introduction
Natural resources have been used for thousands of
years in order to combat human diseases. Over the last
decade the interest in natural products and their
mechanisms of action has been intensified and now
naturally occurring substances play an increasing role
in drug discovery and development. Natural com-
pounds are subjected to miscellaneous chemical
transformations with the use of different chemicals
in order to obtain numerous new derivatives. The
semisynthetic compounds obtained as a result of such
transformations often exhibit more advantageous
pharmacological activity than mother compounds.
The natural triterpenes are created by living tissues
of numerous higher plants. As an example, oleanolic
acid, one of the most popular triterpenic acid can be
isolated from above 1,600 species of plants (Yeung and
Che 2009). Triterpenes can be also created by tissues of
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some fungi, e.g. such as Ganoderma lucidum (Smina
et al. 2011), Inonotus obliguus (Yin et al. 2008) or
Pisolithus tinctorius (Zamuner et al. 2005). This group
of compounds exhibit a wide range of chemical
diversity and biological properties. The pharmacolog-
ical tests proved e.g. anticancer (Braga et al. 2007),
antiviral (Pompei et al. 2009), antibacterial (Fontanay
et al., 2008), hepatoprotective (Szuster-Ciesielska
et al. 2011), cardiovascular, antihyperlipidemic, anti-
oxidant (Somova et al. 2003), anti-inflammatory
(Huguet et al. 2000), antiulcer (Queiroga et al. 2000),
analgesic and antinociceptive (Oliveira et al. 2005),
antidiabetic (Teodoro et al. 2008) and another effects
of many triterpenes. Viral and cancer diseases are now
one of the greatest problem for humans, because of
many complicated mechanisms of action of viruses
and cancer agents. For this reason the greatest hopes of
doctors and scientists are connected with antiviral and
anticancer activity of natural derived compounds, also
triterpenes.
From a chemical point of view, the most important
triterpenoid structures are oleanane, ursane and lupane
triterpenoids and less known triterpenes belong to
dammarane, euphane and taraxastane group.
Scheme 1 Some important
chemical transformations of
oleanonic acid (3) or its
methyl ester (4) within
A-ring
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Triterpenes are compounds derived from natural
occuring squalene. After different transformations of
squalene numerous polycyclic triterpenic structures
are formed, mostly with the C-3 hydroxyl group. Often
one or more carboxyl and additional hydroxyl groups
are present as well. Such combination of polycyclic
structure with unsaturated bonds and functional
groups makes the possibility to perform miscellaneous
chemical transformations leading to numerous new
derivatives. Oleanolic acid, one of the broadest
distributed triterpenes, is the excellent example of
chemical reactivity of C-3 hydroxyl group and further
transformations of the obtained product leading to the
receiving of numerous derivatives with advantageous
pharmacological activities.
Hydroxyl group at C-3 position of oleanolic acid (1)
can be subjected to the reaction of esters synthesis
(Scheme 1), e.g. with the use of carboxylic acids, their
anhydrides or acyl chlorides (Zhu et al. 2001; Hichri
et al. 2003; Ma et al. 2000, 2002 Ali et al. 2002; Chen
et al. 2006). The acylation with the appliance of acetic
anhydride in pyridine is the general method for
reversible protecting of C-3 hydroxyl group, e.g.
against the action of oxidizing agents. The alkaline
hydrolysis leads to unblocking of this hydroxyl group.
Oleanolic acid (1) or its methyl ester (2) can be
oxidizied with Jones reagent (Chen et al. 2006; Pungi-
tore et al. 2005) or with pyridinium chlorochromate (Ma
et al. 2000) to the appropriate 3-oxoderivatives (3 or 4,
respectively). The above products are known as olea-
nonic acid (3) and methyl oleanonate (4), respectively.
Formation of reactive C-3 carbonyl function activates
the neighbouring methylene group (at C-2 position) so it
is possible to obtain many new compounds.
Oleanonic acid 3 and its methyl ester 4 can be
subjected to reaction of condensation with aldehydes
or with ethyl formate (Zaprutko 1999; Honda et al.
2000a; Govardhan et al. 1983; Yasue et al. 1973) to
give products 5a–5c, 6a–6c. With phenylhydrazine
oleanonic acid (3) as well as its methyl ester 4 form
products with indole system: 7 and 8, respectively
(Finlay et al. 2002). This type of reaction leading to
such compounds as 7 and 8 is known as Fisher
indolization. Oleanonic acid (3) or its methyl ester (4)
refluxed with 2,4-dinitrophenylhydrazine in acetic
acid afford the appropriate phenylhydrazones (9 and
10, respectively). Heating of oleanonic acid (3) or
methyl oleanonate (4) with hydroxylamine hydrochlo-
ride affords the appropriate oximes (11 and 12,
respectively). Oxime function can be next subjected
e.g. to the reaction of reduction, acylation, cyclization
to oxazole ring, Beckmann rearrangement.
Similar transformations can be also performed for
lupanes (e.g. betulin, betulinic acid, lupeol) and
glycyrrhetinic acid.
According to our knowledge newly obtained O-
acyloxyimino compounds are known only within
lupanes and oleananes. Such type of compounds (with
the acyloxyimino function) presents perspective phar-
macological activities, such as anticancer, anti-HIV or
anti-inflammatory.
Acyloxyimino derivatives of lupanes
In 1998 (Sun et al. 1998) the method of synthesis and
the test of activity against HIV-1 virus of betulin
derivatives were published. Betulin (13), one of the
most often occured triterpene with lupane skeleton,
was oxidizied with pyridinium chlorochromate (PCC)
to betulonic aldehyde 14 (Scheme 2). The dicarbonyl
compound 14 obtained with this method in the
reaction with hydroxylamine hydrochloride formed
dioxime 15. Next the triterpene 15 was transformed
into product 16a with the appliance of 3,3-dimethyl-
glutaryl anhydride and DMAP in refluxing pyridine, as
presented in Table 1 (route 1).
The newly obtained derivative 16a as well as its
mother dicarbonyl compound 15 were subjected to
biological tests for anti-HIV activity in acutely
infected H9 lymphocytes. For H9 lymphocytes the
values of IC50 and EC50 for dioxime 15 were 5.47 and
1.07 lM, respectively (Table 2), and for diacylderiv-
ative 16a were 15.4 and 4.57 lM, respectively.
The action of acetic anhydride at 120 C for 2 h
upon dioxime 15 (Pohjala et al. 2009) gave product
16b, in which the oxime group at C-3 atom was also
acetylated but in the same time the second oxime
function, at C-28 position, was reduced to the nitrile
one; this new compound 16b was obtained with the
yield of 34 %.
The primary screen of betulin, the above obtained
derivatives 15 and 16b, as well as another acyl
derivatives of betulin against SFV (Semliki Forest
Virus), combined with a counterscreen for Huh-7 cell
viability, was run in order to determine the tentative
inhibitory potential of each compound. The results of
these tests were expressed as surviving fractions
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(remaining percentages of viral replication or cell
viability) after exposure to each compound. Betulin
(13) yielded 7 % virus SFV replication (Table 2) and
83 % cell Huh-7 viability; for dioxime 15 these values
were 121 and 80 %, respectively. The introduction of
acetoxyimino function instead of C-3 hydroxyl one
and a nitrile moiety at C-28 led to 73 % virus
replication and 85 % cell viability.
The next information on acyloxyimino derivatives
of lupane triterpenes was published in 2004 (Flekhter
et al. 2004). In order to obtain such compounds,
betulin (13) was transformed into betulonic acid (17),
methyl betulonate (18) and 28-oxo-allobetulon (19)
with the use of known methods (Scheme 3). The
resulted 3-oxoderivatives 17, 18 and 19 were sub-
jected to the reaction with hydroxylamine hydrochlo-
ride in anhydrous pyridine which led to the obtaining
of appropriate oximes (20, 21 and 22) with high yields.
The compounds 20, 21 and 22 acylated in anhydrous
benzene with carboxylic acid anhydrides (acetic,
succinic or phthalic anhydride, Table 1, route 2) gave
acylated oximes 23a–23c, 24a–24c, 25a–25c with the
yields from 64 % to 77 %.
The obtained oximes of betulin (20, 21 and 22)
were tested for their antiviral activity with the use of
cell cultures inoculated with type 1 HSV virus,
A/FPV/Rostock/34 (H7N1) influenza virus and
ECHO-6 enterovirus. The antiviral effect was judged
by reduction of the viral titer in the presence of test
compounds in comparison to control sample and
characterized by the effective concentration causing a
50 % inhibition of the virus growth (EC50) and by the
ratio of a maximum tolerable drug concentration
(MTC) to EC50. The MTC values were determined
upon 72-h incubation of noninfected cell cultures. As
the result showed, the most active compound turned to
be the oxime of betulonic acid (20). The EC50 values
with respect to viruses: H7N1, HSV-1 and ECHO-6
for this compound were, respectively: 2.17, 81.56 and














   13 (betulin)                                                                                          14
16a, b  15
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Scheme 2 The synthesis
of acylated oximes 16a,
16b derived from betulin
(13)
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respectively: 392.16, 1.30 and 6.09. More active
against HSV-1 virus was only the compound 21, with
methylated carboxyl function, for which EC50 value
was 31.32 lM and MTC value was 6.60.
The further study concerning acylated oximes of
betulinates was published in the same year by
Mukherjee and et al. (2004). Betulinic acid was
converted into betulonic acid (17) upon the action of
Jones reagent (Scheme 4) and then the reaction of the
3-oxo compound (17) with hydroxylamine hydrochlo-
ride in the presence of sodium acetate afforded the
appropriate oxime 20. The obtained hydroxyimino
derivative 20 was subjected to the action of acetyl
chloride or p-toluenesulfonyl chloride in DMF to
obtain, respectively, compound 23a known from the
earlier presented publication and new product 23d.
The obtained compounds 20, 23a and 23d as well as
another compounds obtained in this work, were
subjected to biological tests to determine their cyto-
toxic activity against 9 lines of cancer cells: MOLT-4,
Jurkat E6.1, CEM.CM3 (human lymphoblastic leuke-
mias), BRISTOL8 (human B cell lymphoma), U937
(human histiocytic lymphoma), DU145 (human pros-
tate cancer), PA-1 (human ovary cancer), A549 and
L132 (human lung cancers). The ED50 values (50 %
effective dose) for oxime 20 varied from 0.7 lg/ml for
PA-1 cell line to 2.6 lg/ml for CEM.CM3 (Table 2),
for acyloxyimino 23a were from 2.2 lg/ml (MOLT-4)
to more that 10 lg/ml (A549) and for derivative 23d
varied from 1.5 lg/ml (CEM.CM3) to[10 lg/ml (for
A549 and L132 cell lines). The compounds 20 and 23d
were more active towards the tested cancer cell lines
than betulinic acid only for PA-1 cell line (ED50 for
betulinic acid for PA-1 was[10 lg/ml); ED50 values
for derivatives 20 and 23d and for PA-1 cell line were,
respectively, 3.7 and 1.8 lg/ml.
Genet et al. (2010) synthesized further acyl deriv-
atives of betulonic acid oxime 20 upon the action of
carboxylic acid anhydrides in refluxed pyridine
(Scheme 4, 23a and 23e–23h; Table 1, route 3). The
yields of the synthesized acylated oximes of betulonic
acid 23a and 23e–23h were from 63 to 86 %.
The obtained compounds were evaluated for their
TGR5 agonist potency expressed as EC50 and as an
efficacy. TGR5 is a recently identified G-protein
coupled receptor which attracts scientific attention in
the field of glucose metabolism. This receptor agonist
could be used to treat type 2 diabetes because its
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Table 2 Pharmacological activity of acylated oximes of triterpenes and their mother compounds
Compound Results Activity Literature
13 (betulin) IC50 = 43.7 lM Antiviral (HIV acutely
infected H9
lymphocytes)
Sun et al. (1998)
15 (dioxime of 13) IC50 = 5.47 lM
16a (di-O-acyl deriv. of 15) IC50 = 15.4 lM
13 (betulin) EC50 = 23.0 lM Antiviral (HIV acutely
infected H9
lymphocytes)
15 (dioxime of 13) EC50 = 1.07 lM
16a (di-O-acyl deriv. of 15) EC50 = 4.57 lM
13 (betulin) VR = 7 % Antiviral (SFV) Pohjala et al. (2009)
15 (dioxime of 13) VR = 121 %
16b (di-O-acyl deriv. of 15) VR = 73 %
13 (betulin) CV = 83 %
15 (dioxime of 13) CV = 80 %
16b (di-O-acyl deriv. of 15) CV = 85 %
20 (oxime of BA) EC50 = 2.17 lM Antiviral (influenza A) Flekhter et al. (2004)
21 (oxime of MB) EC50 [ 25.84 lM
22 (oxime of 20-OAB) EC50 = 150.54 lM
20 (oxime of BA) MTC/EC50 = 392.16
21 (oxime of MB) MTC/EC50 \ 1
22 (oxime of 20-OAB) MTC/EC50 = 2.83
20 (oxime of BA) EC50 = 81.56 lM Antiviral (HSV 1)
21 (oxime of MB) EC50 = 31.32 lM
22 (oxime of 20-OAB) EC50 = 160.07 lM
20 (oxime of BA) MTC/EC50 = 1.30
21 (oxime of MB) MTC/EC50 = 6.60
22 (oxime of 20-OAB) MTC/EC50 = 2.66
20 (oxime of BA) EC50 = 4.19 lM Antiviral (ECHO 6)
21 (oxime of MB) EC50 = 36.84 lM
22 (oxime of 20-OAB) EC50 = 133.10 lM
20 (oxime of BA) MTC/EC50 = 6.09
21 (oxime of MB) MTC/EC50 = 11.22
22 (oxime of 20-OAB) MTC/EC50 = 1.60
BA ED50 = 1.23 lg/ml Cytotoxic (MOLT-4) Mukherjee et al. (2004)
20 (oxime of BA) ED50 = 2.1 lg/ml
23a (O-acyl deriv. of 20) ED50 = 2.2 lg/ml
23d (O-acyl deriv. of 20) ED50 = 2.7 lg/ml
BA ED50 = 0.65 lg/ml Cytotoxic (JurkatE6.1)
20 (oxime of BA) ED50 = 1.8 lg/ml
23a (O-acyl deriv. of 20) ED50 = 2.9 lg/ml
23d (O-acyl deriv. of 20) ED50 = 4.9 lg/ml
BA ED50 = 0.98 lg/ml Cytotoxic (CEM.CM3)
20 (oxime of BA) ED50 = 2.6 lg/ml
23a (O-acyl deriv. of 20) ED50 = 4.2 lg/ml
210 Phytochem Rev (2015) 14:203–231
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Table 2 continued
Compound Results Activity Literature
23d (O-acyl deriv. of 20) ED50 = 1.5 lg/ml
BA ED50 = 0.84 lg/ml Cytotoxic (BRISTOL8)
20 (oxime of BA) ED50 = 1.6 lg/ml
23a (O-acyl deriv. of 20) ED50 = 3.4 lg/ml
23d (O-acyl deriv. of 20) ED50 = 3.3 lg/ml
BA ED50 = 0.69 lg/ml Cytotoxic (U937)
20 (oxime of BA) ED50 = 2.4 lg/ml
23a (O-acyl deriv. of 20) ED50 = 5.5 lg/ml
23d (O-acyl deriv. of 20) ED50 = 4.8 lg/ml
BA ED50 = 1.13 lg/ml Cytotoxic (DU145)
20 (oxime of BA) ED50 = 1.1 lg/ml
23a (O-acyl deriv. of 20) ED50 = 2.9 lg/ml
23d (O-acyl deriv. of 20) ED50 = 2.8 lg/ml
BA ED50 [ 10 lg/ml Cytotoxic (PA-1)
20 (oxime of BA) ED50 = 0.7 lg/ml
23a (O-acyl deriv. of 20) ED50 = 3.7 lg/ml
23d (O-acyl deriv. of 20) ED50 = 1.8 lg/ml
BA ED50 [ 10 lg/ml Cytotoxic (A549)
20 (oxime of BA) ED50 = 1.8 lg/ml
23a (O-acyl deriv. of 20) ED50 [ 10 lg/ml
23d (O-acyl deriv. of 20) ED50 [ 10 lg/ml
BA ED50 = 1.3 lg/ml Cytotoxic (L132)
20 (oxime of BA) ED50 = 1.5 lg/ml
23a (O-acyl deriv. of 20) ED50 = 5.3 lg/ml
23d (O-acyl deriv. of 20) ED50 [ 10 lg/ml
20 (oxime of BA) EC50 = 1.75 lM Antidiabetic (TGR 5) Genet et al. (2010)
23a (O-acyl deriv. of 20) EC50 = 5.00 lM
23e (O-acyl deriv. of 20) EC50 = 3.17 lM
23f (O-acyl deriv. of 20) EC50 = 7.88 lM
23g (O-acyl deriv. of 20) EC50 = 7.73 lM
23h (O-acyl deriv. of 20) EC50 = 3.65 lM
20 (oxime of BA) efficacy = 132
23a (O-acyl deriv. of 20) efficacy = 159
23e (O-acyl deriv. of 20) efficacy = 20
23f (O-acyl deriv. of 20) efficacy = 139
23g (O-acyl deriv. of 20) efficacy = 126
23h (O-acyl deriv. of 20) efficacy = 13
1 (OA) IC50 = 8.0 lM Antiviral (HIV-1) Ma et al. (2000)
11 (oxime of OA) IC50 = 5.5 lM
12 (oxime of MO) IC50 = 9.5. lM
27a (O-acyl deriv. of 11) IC50 = 5.5. lM
28a (O-acyl deriv. of 12) IC50 = 4.0 lM
1 (OA) IC50 = 8.0 lM Antiviral (HIV-1 PR) Ma et al. (2002)
11 (oxime of OA) IC50 = 5.5 lM
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Table 2 continued
Compound Results Activity Literature
12 (oxime of MO) IC50 = 9.5 lM
27a (O-acyl deriv. of 11) IC50 = 5.5 lM
27b (O-acyl deriv. of 11) IC50 = 1.9 lM
28a (O-acyl deriv. of 12) IC50 = 4.0 lM
28b (O-acyl deriv. of 12) IC50 = 16 lM
28c (O-acyl deriv. of 12) IC50 [ 100 lM
1 (OA) IC100 not effective Antiviral (HIV-1 RT)
11 (oxime of OA) IC100 not effective
12 (oxime of MO) IC100 not effective
27a (O-acyl deriv. of 11) IC100 not effective
27b (O-acyl deriv. of 11) IC100 = 1.84 lM
28a (O-acyl deriv. of 12) IC100 not effective
28b (O-acyl deriv. of 12) IC100 = 4.53 lM
28c (O-acyl deriv. of 12) IC100 not effective
1 (OA) CC0 C 110 lM Antiviral (HIV-1 RT)
11 (oxime of OA) CC0 = 266 lM
12 (oxime of MO) CC0 = 51.8 lM
27a (O-acyl deriv. of 11) CC0 = 209 lM
27b (O-acyl deriv. of 11) CC0 = 29.6 lM
28a (O-acyl deriv. of 12) CC0 = 40.9 lM
28b (O-acyl deriv. of 12) CC0 = 145 lM
28c (O-acyl deriv. of 12) CC0 = 31.0 lM
39 (dioxime of oleanonic MGC = 1.20 g/100 cm3
(methylene chloride)
Gelation Hu et al. (2009)
MGC = 0.37 g/100 cm3
(chloroform)
MGC = 2.08 g/100 cm3 (carbon
tetrachloride)
MGC = 0.10 g/100 cm3
(benzene)
MGC = 0.20 g/100 cm3 (toluene)
45d (O-acyl deriv. of 12) GI50 = (1.55–12.80) 9 10
-6 the





GI50 = (1.66–34.80) 9 10
-6 (the




GI50 = (1.56–2.67) 9 10
-6 (the




GI50 = (1.67–16.50) 9 10
-6 (the




GI50 = (2.02–2.78) 9 10
-6 (the
most sensitive cell line: HL-
60 TB)
Anticancer (leukemias)
GI50 = (1.49–2.60) 9 10
-6 (the
most sensitive cell line: UO-31)
Anticancer (kidney
cancers)
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Table 2 continued
Compound Results Activity Literature
GI50 = (1.47–11.50) 9 10
-6 (the




GI50 = (1.76–10.40) 9 10
-6 (the
most sensitive cell line: SF-539)
Anticancer (CNS
cancers)
TGI = (4.04–22.90) 9 10-6 (the
most sensitive cell line: HOP-92)
Anticancer (lung
cancers)
TGI = (3.02–12.60) 9 10-6 (the




TGI = (4.29–14.20) 9 10-6 (the
most sensitive cell line: MCF-7)
Anticancer (brest
cancers)
TGI = (3.08–30.40) 9 10-6 (the




TGI = (5.36–8.16) 9 10-6 (the
most sensitive cell line: HL-
60 TB)
Anticancer (leukemias)
TGI = (2.93–16.30) 9 10-6 (the
most sensitive cell line: UO-31)
Anticancer (kidney
cancers)
TGI = (2.94–24.40) 9 10-6 (the




TGI = (3.37–22.10) 9 10-6 (the
most sensitive cell line: U251)
Anticancer (CNS
cancers)
LC50 = (11.50–100.00) 9 10
-6




LC50 = (6.14–38.80) 9 10
-6 (the




LC50 = (11.10–46.80) 9 10
-6




LC50 = (5.70–60.20) 9 10
-6 (the




LC50 = (2.62–100.00) 9 10
-6
(the most sensitive cell line: HL-
60 TB)
Anticancer (leukemias)
LC50 = (5.79–57.20) 9 10
-6 (the
most sensitive cell line: UO-31)
Anticancer (kidney
cancers)
LC50 = (5.89–51.50) 9 10
-6 (the




LC50 = (6.39–54.90) 9 10
-6 (the
most sensitive cell line: U251)
Anticancer (CNS
cancers)
1 (OA) MGIR = 22.4 % Fungicidal (Candida
albicans GlcN-6-P
synthase inhibitor);
conc. = 0.35 mM
Zhao et al. (2013)
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Table 2 continued
Compound Results Activity Literature
50a (O-acyl deriv. of 11) MGIR = 29.4 %
50b (O-acyl deriv. of 11) MGIR = 37.2 %
50c (O-acyl deriv. of 11) MGIR = 40.8 %
50d (O-acyl deriv. of 11) MGIR = 19.2 %
50e (O-acyl deriv. of 11) MGIR = 30.8 %
50f (O-acyl deriv. of 11) MGIR = 29.1 %
50 g (O-acyl deriv. of 11) MGIR = 22.9 %
50 h (O-acyl deriv. of 11) MGIR = 24.8 %
50i (O-acyl deriv. of 11) MGIR = 21.0 %
50j (O-acyl deriv. of 11) MGIR = 20.5 %
51a (O-acyl deriv. of 49) MGIR = 8.7 %
51b (O-acyl deriv. of 49) MGIR = 12.2 %
51c (O-acyl deriv. of 49) MGIR = 19.8 %
51d (O-acyl deriv. of 49) MGIR = 16.2 %
51e (O-acyl deriv. of 49) MGIR = 20.2 %
51f (O-acyl deriv. of 49) MGIR = 34.2 %
51 g (O-acyl deriv. of 49) MGIR = 28.2 %
51 h (O-acyl deriv. of 49) MGIR = 12.7 %
51i (O-acyl deriv. of 49) MGIR = 19.3 %
51j (O-acyl deriv. of 49) MGIR = 13.2 %
51 k (O-acyl deriv. of 49) MGIR = 16.4 %
51 l (O-acyl deriv. of 49) MGIR = 33.0 %
51 m (O-acyl deriv. of 49) MGIR = 33.1 %
51n (O-acyl deriv. of 49) MGIR = 12.5 %
51o (O-acyl deriv. of 49) MGIR = 13.8 %
1 (OA) MGIR = 1.0–25.3 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
Fungicidal;
conc. = 50 lg/ml
50a (O-acyl deriv. of 11) MGIR = 1.8–61.2 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
50b (O-acyl deriv. of 11) MGIR = 8.4–61.2 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
50c (O-acyl deriv. of 11) MGIR = 3.1–42.7 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
50d (O-acyl deriv. of 11) MGIR = 15.8–53.5 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
50e (O-acyl deriv. of 11) MGIR = 6.5–73.0 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
50f (O-acyl deriv. of 11) MGIR = 4.0–33.5 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
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Table 2 continued
Compound Results Activity Literature
50 g (O-acyl deriv. of 11) MGIR = 6.1–67.6 % (the most
sensitive cell line: Phytophthora
parasitica Dast)
50 h (O-acyl deriv. of 11) MGIR = 2.0–27.8 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
50i (O-acyl deriv. of 11) MGIR = 1.4–25.1 % (the most
sensitive cell line: Rice blast)
50j (O-acyl deriv. of 11) MGIR = 2.3–30.3 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
51a (O-acyl deriv. of 49) MGIR = 9.4–79.2 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
51b (O-acyl deriv. of 49) MGIR = 12.0–71.1 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
51c (O-acyl deriv. of 49) MGIR = 23.5–93.6 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
51d (O-acyl deriv. of 49) MGIR = 25.9–74.3 % (the most
sensitive cell line: Rice blast)
51e (O-acyl deriv. of 49) MGIR = 17.4–84.1 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
51f (O-acyl deriv. of 49) MGIR = 18.1–73.1 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
51 g (O-acyl deriv. of 49) MGIR = 17.7–86.1 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
51 h (O-acyl deriv. of 49) MGIR = 21.7–67.8 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
51i (O-acyl deriv. of 49) MGIR = 25.3–74.4 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
51j (O-acyl deriv. of 49) MGIR = 23.5–68.2 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
51 k (O-acyl deriv. of 49) MGIR = 21.4–64.5 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
51 l (O-acyl deriv. of 49) MGIR = 28.2–69.5 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
51 m (O-acyl deriv. of 49) MGIR = 24.6–66.7 % (the most
sensitive cell line: Sclerotinia
sclerotiorum (Lib.) de Bary)
51n (O-acyl deriv. of 49) MGIR = 30.8–77.6 % (the most
sensitive cell line: Rhizoctonia
solani Kuhn)
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activity, which deficiency is the feature of the early
stage of the diabetes. The EC50 value for compounds
23a and 23e–23h varied from 3.17 to 7.88 lM
(Table 2) and the efficacy from 13 to 159 %, in
comparison to mother betulinic acid (17), with an
EC50 of 1.04 lM and an efficacy of 83 %.
As Nekrasov et al. reported (2005), allobetulon
oxime 25 obtained from betulin 13 and refluxed for
30 min in anhydrous toluene with equimolar amount
of 5-phenyl-2,3-dihydrofuran-2,3-dione gave unex-
pected product 26 (Scheme 5).
Usually, primary and secondary alcohols open up
the ring of 5-aryl-2,3-dihydrofuran-2,3-diones at room
temperature, to form the corresponding aroylpyruvic
acid esters. To the contrary, allobetulone oxime (25)
subjected to the action of 5-phenyl-2,3-dihydrofuran-
Table 2 continued
Compound Results Activity Literature
51o (O-acyl deriv. of 49) MGIR = 28.7–85.5 % (the most
sensitive cell line: Rice blast)
1 (OA) IC50 = 14.93 lM Anticancer (KB)
53 (oxime of OM) IC50 = 2.06 lM Bednarczyk-Cwynar
et al. (2012b)
54a (O-acyl deriv. of 53) IC50 [ 15.00 lM
54b (O-acyl deriv. of 53) IC50 = 9.42 lM
54c (O-acyl deriv. of 53) IC50 = 4.90 lM
54d (O-acyl deriv. of 53) IC50 = 0.72 lM
54e (O-acyl deriv. of 53) IC50 = 10.10 lM
1 (OA) IC50 = 13.95 lM Anticancer (MCF-7)
53 (oxime of OM) IC50 = 11.27 lM
54a (O-acyl deriv. of 53) IC50 [ 15.00 lM
54b (O-acyl deriv. of 53) IC50 = 7.26 lM
54c (O-acyl deriv. of 53) IC50 = 3.76 lM
54d (O-acyl deriv. of 53) IC50 = 2.13 lM
54e (O-acyl deriv. of 53) IC50 = 9.28 lM
1 (OA) IC50 = 11.82 lM Anticancer (MCF-7)
53 (oxime of OM) IC50 = 1.34 lM
54a (O-acyl deriv. of 53) IC50 [ 15.00 lM
54b (O-acyl deriv. of 53) IC50 = 9.19 lM
54c (O-acyl deriv. of 53) IC50 = 4.41 lM
54d (O-acyl deriv. of 53) IC50 = 1.87 lM
54e (O-acyl deriv. of 53) IC50 = 9.84 lM
55 (GA) GI50 = 63.2 lM Anticancer (HL-60) Liu et al. (2007)
56 (oxime of GA) GI50 = 63.9 lM
57a (O-acyl deriv. of 56) GI50 = 58.8 lM
57b (O-acyl deriv. of 56) GI50 = 57.7 lM
55 (GA) AC = 24.9 %
56 (oxime of GA) AC = 24.5 %
57a (O-acyl deriv. of 56) AC = 19.1 %
57b (O-acyl deriv. of 56) AC = 27.7 %
BA betulinic acid, MB methyl betulinate, 20-OAB 20-oxoallobetulin, OA oleanolic acid, MO methyl oleanolate, GA glycyrrhetinic
acid, IC50 50 % inhibitory concentration, EC50 50 % effective concentration, VR virus replication, CV cell viability, MTC maximum
tolerable concentration, ED50 50 % effective dose, IC100 100 % inhibition concentration, CC0 minimum cytotoxic concentration,
MGC minimum gelator concentration, GI50 50 % growth inhibition, TGI total growth inhibitor, LC50 50 % lethal concentration,
MGIR mycelium growth inhibition rate, AC amount of apoptotic cells
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2,3-dione after decarboxylation gave O-benzoylacetic
acid derivative 26 (Table 1, route 4).
Acyloxyimino derivatives of oleananes
There are also known acylated oximes derived from
triterpenes of oleanane skeleton-oleanolates, masli-
nates and glycyrrhetinates.
Acyloxyimino derivatives of oleanolates
and maslinates
The first derivatives of this type were synthesized and
published in 2000 (Ma et al. 2000). Oleanolic acid (1)
or its methyl ester (2) were oxidizied with pyridinium
chlorochromate and the resulted products (3 and 4)
were subjected to the action of hydroxylamine hydro-
chloride in pyridine (Scheme 6). Next, oxime 11 and
12 were transformed into their O-acyl derivatives 27a
and 28a, respectively, upon the action of adipoyl
dichloride in heated THF or adipic acid and DCC in
THF at room temperature (Table 1, route 5). Com-
pounds 27a and 28a were obtained with the yields,
accordingly, 36 % and almost 98 %.
The obtained derivatives of oleanolic acid (27a and
28a) were tested towards their activity as inhibitors of
HIV-1 dimerization protease (HIV-1 PR). It was stated
that the introduction of acyl function with six-mem-
bered chain into hydroxyimino group intensifies the


























                K2Cr2O7, H2SO4, 
acetone, Al2O3, H2O, rt.
    CH3N2, 
ethyl eter,  rt.
1. K2Cr2O7, H2SO4, 
       acetone, Al2O3, H2O, rt.
             2. HCOOH, 100 oC
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pyridine, reflux
carboxylic acid 
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above mentioned enzyme (Table 2). The IC50 values
for oleanolic acid was 8.0 lM, and for acylated
oximes 27a and 28a, were 5.5 and 4.0 lM,
respectively.
Kimura et al. (1999) decided to obtain new
compounds in which triterpenic molecule with HIV-
1 PR inhibitory activity would be be joined with non-
terpenic molecule with HIV-1 TR inhibitory activity,
such as azidothymidine (AZT). The product of this
type should show much better permeability into cells,
moreover, within the cell the molecule of such
conjugate would break down into two elements of
different types of activity against HIV-1 so would be
excellent antiviral agent.
Ma et al. (2002) acylated the oximes: 11 and 12 also
with hemiester of adipic acid and AZT or FK-3000
(Scheme 6). Both, AZT and FK-3000, are well known
medicines applied in HIV-1 therapy. FK-3000 is an
alkaloid of morphine type, it shows the activity against
Herpex simplex virus and inhibits the synthesis of viral
DNA. Moreover, this compound acts as an inhibitor of
reverse transcriptase of HIV-1 virus with IC100 value
of 7.8 lg/ml (IC100—the minimum concentration for
complete inhibition of HIV-1 induced CPE in MT-4
cells by microscopic observation) and CC0 value:
15.6 lg/ml (CC0—the minimum concentration for
appearance of MT-4 cell toxicity by microscopic
observation), but at the same time it is not active
towards HIV-1 dimerization protease (Ma et al. 2002).
Ma et al. (2002) obtained the oximes 11 and 12 with
the appliance of the earlier described method (Ma et al.
2000). The reaction of oxime acylation was performed
as presented in Table 1, route 6.
The resulted triterpenic derivatives were tested
towards their activity as HIV-1 PR inhibitors and HIV-













23a, 23d - 23f
NH2OH x HCl, CH3COONa, 
            C2H5OH, reflux
acetyl acid or tosyl chloride
DMF, NaH
or carboxylic acid chloride, 
pyridine, DMAp, reflux 
O
23a: R =                ,   23d: R =                        ,   23e: R=                  , 





Scheme 4 The synthesis of
acylated oximes 23a and 23d–
23 h derived from betulonic
acid (17)
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1. FeCl3 x 6H2O, CH2Cl2, rt.















     furan-2,3-dione,
      toluene, reflux
NH2OH x HCl, 
CH3COONa, 
C2H5OH, reflux





27a: R1 2 = H
27b: R1 2 = AZT
28a: R1 = CH3 2 = H
28b: R1 = CH3 2 = AZT
28c: R1 = CH3
 = H, R
= H,   R
, R
,   R
,   R2 = FK 3000











1: R = H (oleanolic acid) 11: R = H
2: R = CH3 (methyl oleanolate) 12: R = CH3
  1. PCC, acetone, CH2Cl2, rt.
2. NH2OH x HCl, pyridine, 50 oC
carb. acid chloride, 
     THF, 60 oC
or: carb. acid chloride, 
     THF, DCC, rt
or: hemiester of carb. acid 
     and FK-300,  DMAP, 
     DCC, CH2Cl2
Scheme 6 The synthesis of
acylated oximes 27a,b and
28a–28c derived from
oleanolic acid (1)
Phytochem Rev (2015) 14:203–231 219
123
dimerization protease was evaluated by HPLC ana-
lysis of the cleavage products of a synthetic substrate.
The IC50 value for AZT was above 100 lM (Table 2),
for oximes acylated with adipic acid (11 and 12) were
5.5 and 4.0 lM, respectively, for compounds with
AZT system (27a and 28a) were 1.9 and 16.0 lM,
respectively, and for acylated oxime with FK-3000
system (28c) the IC50 value also exceeded 100 lM; it
means that this compound in fact was inactive as HIV-
1 PR inhibitor.
The inhibitory activity against HIV-1 reverse
transcriptase of the obtained conjugated compounds
was tested with the use of MT-4 cells. The results were
shown as IC100 and CC0 values.
The derivatives 27a and 28a turned to be practically
inactive, with CC0 values 209.0 and 40.9 lM, respec-
tively (Table 2). The introduction of azidothymidine
system into the molecule of triterpene significantly
increased the activity of compounds: IC100 values for
such compounds (27b and 28b) were: 1.84 and
4.53 lM, respectively, the CC0 values were 145.0
and 120.0 lM, respectively. The triterpenic derivative
with FK-3000 system (28c) was inactive, with CC0
value 31.0 lM.
The insignificant inhibitory activity of product 28c,
both, against reverse transcriptase of HIV-1 and
dimerization protease of HIV-1 (Table 2) can be
caused by limited permeation of triterpene into cell
and/or by high stability of amidic bound within this
compound which makes impossible the cleavage of
the molecule into two elements with different ways of
activity against HIV-1 virus.
The next acylated oximes of oleanolic acid were
obtained by Honda et al. (2004) (Scheme 7). The
diketone 29 was obtained as a result of six-step set of
reactions, starting from methyl oleanolate 2 (Honda
et al. 2000b). Compound 29 was subjected to the
reaction with hydroxylamine hydrochloride in
refluxed methanol with methylene chloride. The
product of this reaction was compound 30 with
hydroxyimino group only at C-3 position.
In the next steps, monooxime 30 was transformed
into complex 31 and after that into diacetoxy deriv-
ative 32, as it is presented in Table 1, route 7. Crude
final product 32 was obtained with the yield of 56 % in
comparison to oxime 30.
The similar acyloxyimino derivative obtained via


















  29 (derivative of                                                                                                        30 
methyl oleanolate 2)
32 31
NH2OH x HCl, CH3COONa, 












1: DMAP, Et3N, CH2Cl2, rt.
2: THF, pyridine, rt.
3: Pb(CH3COO)4, CH3COOH, -78 oC, next rt.
4: NaBH4, NaOH, rt
Scheme 7 The synthesis of
acylated oximes 31 and 32
derived from oleanolic acid (1)
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maslinic acid methyl ester (33) (Garcı´a-Granados et al.
2007), which differs from oleanolic acid methyl ester
(2) only in the presence of an additional a-hydroxyl
group at C-2 position (Scheme 8). Starting from
methyl maslinate (33), after blocking of C-2 hydroxyl
group, the appropriate oximes (34a, 34b) were
obtained. Next, the above compounds (34a and 34b)
were transformed into acetyloxyimino derivatives
(36a and 36b, respectively) in the same conditions
and by means of using of the same reagents as for
methyl oleanolate (2) (Table 1, route 7). The above
compounds, 36a and 36b, were received with the
yields of 44 and 35 %, respectively.
Hu et al. (2009) obtained derivatives of oleanolic
acid with two oxime groups which were then acylated.
Oleanolic acid (1) or its methyl ester (2) were
oxidizied with Jones reagent in acetone to the
appropriate ketones 3 and 4, respectively. Next the
oxoderivatives 3 and 4 were subjected to the action of
n-butyl nitrite and as a result a-ketooximes 37 and 38,
respectively, were obtained (Scheme 9). These
compounds were next refluxed in pyridine with
hydroxylamine hydrochloride and yielded a-dioxi-
mes: 39 and 40, respectively. The compound 39
reacted with acetic anhydride at room temperature in
pyridine in the presence of DMAP (Table 1, route 8) to
afford diacetyloxime 41 with the yield of 51 %.
The last compound 41 as well as dioxime 39 were
tested to estimate their possibility to form organogel
(Hu et al. 2009). This type of compounds are faced
with many interest nowadays because of their inter-
esting possibilities of application.
The gel formation ability was determined by a
‘‘stable to inversion of the test-tube’’ method. Specific
amount of the tested compound was added into 15
different organic solvents at room temperature and
these mixtures were heated to form transparent liquid,
then cooled to room temperature to observe whether or
not the immobile gel was formed in the inverted test-
tube.
As it was shown on the basis of the obtained results,
complete gel formation occurred in benzene, toluene
Na2PdCl4, CH3COONa, 
CH3COOH, rt.
1: DMAP, Et3N, CH2Cl2, rt.
2: THF, pyridine, rt.
3: Pb(CH3COO)4, CH3COOH, -78 oC, next rt.
4: NaBH4, NaOH, rt
 33 (methyl maslinate) 34a: R = CH3CO










36a: R = CH3CO                                                                                     35a: R = CH3CO



















    1. (CH3CO)2O, pyridine, rt. 
      or benzoyl chloride, rt.
   2. Jones reagent, acetone, rt
3. NH2OH x HCl, pyridine, 50 oC
Scheme 8 The synthesis of acylated oximes 35a,b and 36a,b derived from methyl maslinate (33)
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and simple chlorinated solvents, such as methylene
chloride, chloroform or carbon tetrachloride and the
best solvent for the gelation process turned out to be
benzene, in which gelation of dioxime 39 at a
concentration as low as 0.10 g/100 cm3 occurs within
5 min (Table 2). Another organogels, obtained with
the use of other organic solvents, were formed at
concentrations from 0.2 g/100 cm3 to 2.08 g/
100 cm3. For dioxime 41 gelation was not observed.
It suggested that the presence of free hydroxyimino
and carboxyl groups is favourable for gelation process.
When the stable gel formed in benzene was
treated with HCl or gaseous NH3, it became
unstable and eventually transformed into a suspen-
sion. This effect was caused by the deprotonisation
or protonisation of the hydroxyimino and carboxyl
groups within the molecule of dioxime 39 and the
salts were formed. All these results confirmed the
earlier thesis that the free hydroxyimino and
carboxyl groups were significant to the gelation
and the intermolecular hydrogen bonding played a
crucial role in the formation of stable gels.
Acyl derivatives of oleanolic acid oximes can also
be effective anticancer agents. With a view to obtain
compounds with such activity, Bednarczyk-Cwynar
et al. (2011) transformed oleanolic acid (1) and its
methyl ester (2) into appropriate oximes (11, 12, 42
and 43, Scheme 10a), also with C-11 oxo group, with
the use of modified methods from literature (Ma et al.
2000; Yasue et al. 1974).
The received oximes 11, 12, 42 and 43 (Sche-
me 10a) were subjected to acylation with the appli-
ance of carboxylic acids in dried dioxane or THF in the
presence DCC at room temperature (Table 1, route 9).
Pure acylated oximes of oleanolic acid (44a–44h,
45a–45h, 46a–46h and 47a–47h) were obtained with
the yields of 86–96 %.
The oximes of oleanolic acid 11, 12, 42 and 43 as
well as their derivatives obtained by acylation of the
above oximes with heterocyclic carboxylic acids
(44c–h, 45c–h, 46c–h, 47c–h) were subjected to the
biological tests in order to estimate their cytotoxic
acitivity against selected cancer cell lines. The tests
were conducted with the use of doxorubicin eluting
beads (DEB) and the procedure according to NCI
methods (Monks et al. 1991; Boyd and Paull 1995), in
which the cancer cell lines of different type of lung,
colon, breast, ovary, kidney, prostate, CNS as well as
leukemia and melanoma, provided a research material.
Anticancer activity of the tested compounds was
determined with the use of spectrophotometric method
based on sulphorodamine B as an agent linked
selectively to proliferating proteins of the tested cells.
The results were presented as a percentage of increase





1: R = H (oleanolic acid)                                                                                                      37: R = H
2: R = CH3 (methyl oleanolate)                 38: R =CH3
41: R = H                                                                                                   39: R = H














1. Jones reagent, acetone, rt.
      2. t-BuOK, t-BuOH, 
          n-BuONO2, rt.




Scheme 9 The synthesis of
acylated oxime 41 derived
from oleanolic acid (1)
222 Phytochem Rev (2015) 14:203–231
123
The tested acyloxyimino triterpenes turned to be
moderately active towards most of the used cell lines,
the decrease of the amount of surviving cancer cells
was in some cases higher than 50 %. On the basis of
the obtained results it can be stated that the anticancer
activity of the tested triterpenes is dependent on the
structure of carboxylic acid connected to oxime
moiety. The most active compounds were 45d, 45e,
45g and 45h, all of them with esterified carboxyl group
within the triterpene moiety and with thiazolidine ring
within acyl group. The highest level of anticancer
activity exhibited the derivative 45d, so taking under
consideration the structure of the obtained products
and their anticancer activity, it can be stated that the
advantageous element of the structure, influencing on
the level of anticancer activity, can be N–H group
within thiazolidine ring. The decrease of the amount of
cancer cells exceeded 50 % for most types of lungs
and breast cancer lines as well as for almost all types of
leukemia.
For the derivative 45d, with the highest level of
anticancer activity, the additional biological tests were
performed for the concentrations from 10-4 to
10-8 M. On the basis of the obtained data the most
characteristic parameters: GI50, TGI and LC50 were
estimated.
The GI50 values for the most sensitive cell lines
ranged from 1.47 9 10-6 (LOX IMVI cell line) to
2.02 9 10-6 for HL-60 TB (Table 2); TGI values






















1. Jones reagent, acetone, rt.
2. NH2OH x HCl, CH3COONa, 
    C2H5OH, reflux
11 12
         1. (CH3)2SO4, C2H5OH, KOH, reflux
    2. Jones reagent, acetone, rt.
3. NH2OH x HCl, CH3COONa, C2H5OH, reflux
1. (CH3)2SO4, C2H5OH, KOH, reflux
2. (CH3O)2O, pyridine, rt.
3. K2Cr2O7 x 2 H2O, CH3COOH, 60 oC
4. NaOH, C2H5OH, reflux
  5. Jones reagent, acetone, rt.
          6. NH2OH x HCl, CH3COONa, 
                     C2H5OH, reflux
1. (CH3O)2O, pyridine, rt.
2. SOCl2, rt.
3. benzene, morpholine, rt.
4. NaOH, C2H5OH, reflux
5. Jones reagent, acetone, rt.
6. NH2OH x HCl, CH3COONa, C2H5OH, reflux
1 (oleanolic acid) 
43
42
aScheme 10 a The synthesis of
oximes 11, 12, 42 and 43
derived from oleanolic acid
(1). b The synthesis of acylated
oximes 44a–44h, 45a–45h,
46a–46h and 47a–47h derived
from oleanolic acid (1)
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5.36 9 10-6 (HL-60 TB) and the LC50 values were
found from 2.62 (HL-60 TB) to 11.5 (HOP-92). The
obtained results of the cytotoxicity of the oleanolic
acid acylated oximes expressed in a form of the above
parameters, pointed at potent antileukemic activity of
the triterpenic oximes acylated with some carboxylic
acids containing thiazolidone moiety. In molecules of
the most potent antileukemic products thiazolidone
skeleton was joined with carboxyl function via short
carbon chain.
As the literature data proved (Bednarczyk-Cwynar
et al. 2012a) the methyl oleanolate 3-oxime acylated
with fatty acid can be active analgesic and anti-
inflammatory agent. In order to obtaine this type of
compound oleanolic acid (1) was transformed into its
methyl ester oxime (12) in three-step set of reactions
(Scheme 11). The obtained hydroxyimino compound
(12) was acylated with octanoic acid in the presence of
DCC in THF (Table 1, route 10). The product 48 was
received with the yield of about 93 %.
The new compound 48 was subjected to acute
toxity, locomotor activity, analgesis activity and anti-
inflammatory tests.
For toxicity studies, the group of mice were
administered triterpene 48 (p.o.) in the dose of 2.0 g/






11,   44a - 44h:    R1 = H2,  R2 = OH
12,   45a - 45h:    R1 = H2,  R2 = OCH3
42,   46a - 46h:    R1 = O,   R2 = OCH3
43,   47a - 47h:    R1 = H2,  R2 = morpholine ring
carboxylic acid, dioxane 
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(derivatives of oleanolic acid 1)
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Scheme 10 continued
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not cause any changes in skin and mucous appearance,
cardiovascular, respiratory and central nervous system
function and mortality during the next 14 days prov-
ing non toxic effects upon mice. In locomotor activity
tests, horizontal and vertical locomotor activities of
mice were evaluated using an activity meter which
recorded spontaneous activity of animals in the time of
30 and 60 min after triterpene 48 administration in the
dose of 3.0, 30.0, 100.0 and 300.0 mg/kg intragastri-
cally (p.o.). It was found that compound 48 did not
affect horizontal activity of mice in doses of 3.0, 30.0
and 100.0 mg/kg in both periods, but after adminis-
tration of 300.0 mg/kg m.c. an increase in activity was
observed. Moreover, similar effects in vertical activity
were observed.
In analgesic activity test pain reflexes of mice in
response to a thermal stimulus were measured in hot
plate test after the same way of application and the same
doses of triterpene 48 in the time of 30, 60, 90 and
120 min following the application. For comparative
purposes, morphine in a dose of 5.0 mg/kg (s.c.) was
administered to mice. It was observed that the compound
48 showed analgesic activity in the dose of 300.0 mg/kg
and 60 min after administration. The combined treat-
ment of triterpene 48 and morphine showed stronger
analgesic activity in the doses of 30.0 and 300.0 mg/kg
in comparison to morphine effect after 60 min.
In the next test, skin inflammation was induced in
the right hindpaw of rats by the topical application of
2 mg/paw of carrageenan dissolved in 0.2 ml of 0.9 %
saline solution. To the control, the rear left paw of the
rats received the same volume of 0.9 % saline solution.
Single doses of the compound 48 in range of 0.3, 3.0,
30.0 and 300.0 mg/kg were given intragastrically
(p.o.) 30 min after carrageenan injection. For compar-
ison, one group of rats was treated with the acute
diclofenac (50 mg/kg, i.p.) injected 60 min after
carrageenan administration. The interaction between
methyl 3-octanoyloxyiminoolean-12-en-28-oate (48)
(30 mg/kg, p.o.) and diclofenac was also tested. The
rate of oedema of the two paws was measured at 1.5,
3.0, 6.0, and 10.0 h after carrageenan injection using a
plethysmometer. The triterpene 48 caused a significant
antioedemic effect in all doses after 1.5 and 3 h after
carrageenan application in comparison to the control.
The effect was also observed in three smallest doses
after 6 h and in the dose of 3.0 mg/kg after 10 h from
carrageenan application.
Zhao et al. (2013) proved moderate antifungal
activity of acylated oximes of oleanolic acid. In order
to obtain these compounds, oleanolic acid (1) was
transformed into its methyl or benzyl esters and next
into the appropriate oximes 11 and 49, respectively
(Scheme 12). Next, hydroxyimino derivatives 11 and
49 were subjected to the action of carboxylic acids in
refluxed methylene chloride in the presence of DCC to
give the desired products 50a–50j and 51a–51o with
the yields of 70–93 % (Table 1, route 11).
Zhao et al. (2013) presented that preliminary
studies based on Elson–Morgan method (Roseman
and Dafner 1956) proved some inhibitory activity of
glucosamine-6-phosphate synthase (GlmS) of many
compounds among the triterpenic derivatives 50a–50j
and 51a–51o. The GlmS is the enzyme that plays a key
role in the biosynthesis of the bacterial and fungal
saccharides that are crucial elements of cell wall.
Inhibitory activity of all the synthesized compounds
was tested towards Candida albicans GlcN-6-P syn-
thase. The Elson-Morgan method was based on
colorimetry where the absorption value of the solution
was measured at 585 nm, and then the concentration
was counted on the basis of calibration curve.
Among the compounds 50a–50j and 51a–51o
tested by Zhao et al. (2013) only the derivatives 50b,
50c, 51f, 51l and 51m turned out to be more active
against glucosamine-6-phosphate synthase than ole-
anolic acid (1) and exhibited the inhibition rate at
0.35 mM, respectively 37.2, 40.8, 34.2, 330 and
33.1 % (Table 2) in comparison to 22.4 % for mother











(oxime of methyl oleanonate)
octanoic acid, 
THF, DCC, rt.
Scheme 11 The synthesis of
acylated oxime 48 derived
from oleanolic acid (1)
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The fungicidal activity of the obtained oleanolic
acid acylated oximes 50a–50j and 51a–51o Zhao et al.
evaluated against Sclerotinia sclerotiorum (Lib.) de
Bary, Phytophthora parasitica Dast, Botrytis cinerea
Pers, Rhizoctonia solani Kuhn, Rice blast and
Fusarium wilt using the mycelium growth rate test
(Zhao et al., 2013). The diameter of the mycelia was
measured and the inhibition rate was calculated.
The inhibition rate for S. sclerotiorum ranged from








1 (oleanolic acid)                                                                                                        11: R1 = H
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51m: R2 =                          ,     51n: R2 =                            ,      51o: R2 =                                   
1. benzyl bromide, K2CO3, DMF, 
    rt (for synth. of 49)
2. PDC, (CH3CO)2O, CH2Cl2, reflux
    (for synth. of 11 and 49)
3. NH2OH x HCl, pyridine, 80 oC
    (for synth. of 11 and 49)
Scheme 12 The synthesis of
acylated oximes 50a–50j and
51a–51o derived from
oleanolic acid (1)
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was from 1.8 % (50a) to 67.6 % (50g) (Table 2), for
B. cinerea ranged from 1.4 % (50i) to 69.1 % (51i),
for R. solani from 5.5 % (50j) to 93.6 % (51c), for
Rice blast waried from 21.0 % (50e, 50f) to 85.5 %
(51o) and for Fusarium wilt ranged from 5.1 % (50j)
to 36.7 % (51c). In the same conditions oleanolic acid
(1) exhibited the inhibition rate for this 6 fungi from
1.0 % (for B. cinerea) to 25.3 % (for R. solani).
The other group of acylated oximes originated from
oleanolic acid methyl ester (2) was obtained and
described also by Bednarczyk-Cwynar et al. (2012b).
It was the first described synthesis of acylated oximes
within C ring of oleanane molecule (Scheme 13).
These new compounds were obtained as follows:
first, methyl oleanolate (2) was acetylated with acetic
anhydride in anhydrous pyridine according to litera-
ture protocol (Honda et al. 1997) and the resulted
product was subjected to own-modified peracid oxi-
dation (m-CPBA) in methylene chloride, based on
literature data (Okamoto et al. 2000). After purifica-
tion with column chromatography on SiO2 12-oxo-
compound 52 was exposed to the action of
hydroxylamine hydrochloride in ethanol according to
a known method (Mukherjee et al. 2004). After that
the resulted pure oxime 53 was acylated in dioxane
with small excess of carboxylic acids in the presence
of DCC at room temperature (Table 1, route 12). The
resulting products 54a–54e were obtained with the
yields of above 90 %.
As the literature data showed (Soldi et al. 2008) the
introduction of acyl group with short or slightly longer
unbranched chain into the molecule of triterpene can
improve the pharmacological activity of the new
substance. On the basis of these results 12-ketone 52,
12-oxime 53 and 12-acyloxyimino compounds 54a–
54e were subjected to the biological tests on order to




















54a - 54e  53
1. (CH3CO)2, pyridine, rt.
2. m-CPBA, CH2Cl2, rt.
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CH3COONa, 
C2H5OH, reflux
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Oleanolic acid (1) as a reference compound and
12-ketone 52, 12-oxime 53 as well as acyloxyimin-
oderivatives 54a–54e were tested as to their cytotoxic
activity against KB, MCF-7 and HeLa cell lines.
Oleanolic acid (1) turned to be moderately active, with
IC50 value for 14.93, 13.95 and 11.82 lM/l, respec-
tively (Table 2). The introduction of propionoxyimino
function at C-12 position resulted in significant
intensification of anticancer activity, especially
against KB cells. This derivative (54d) was about
21-fold more active against the above mentioned cell
line (IC50 of 0.72 lM/l) than oleanolic acid (1), and
about 6.5-fold more active against MCF-7 and HeLa
cells (IC50 of 2.13 and 1.87 lM/l, respectively).
Acyloxyimino derivatives of glycyrrhetinates
Simple acylated oximes are also known within
glycyrrhetinates that are compounds with oleanane
skeleton (Liu et al. 2007).
Glycyrrhetinic acid (55) was oxidizied at C-3
position with the use of Jones reagent and next
subjected to the action of hydroxylamine hydro-
chloride to give oxime 56 (Scheme 14). Next, the
oxime 56 was transformed into its O-acyl
derivatives upon the action of acetic or propionic
anhydride in refluxed pyridine in the presence of
catalytic amount of DMAP (Table 1, route 13). The
crude products 57a and 57b were obtained with the
yields of about 70 %.
Glycyrrhetinic acid (55) is a well known compound
that inhibits growth and induces apoptosis of cancer
cells. The antiproliferative and antiapoptotic effects
for the above acid and its derivatives, e.g. acyloxyi-
mino ones were determined with the use of human
leukemia HL-60 cells.
The antiproliferative activity of glycyrrhetinic acid
derivatives was determined by direct counting of
leukemia cells which, as the first, were subjected to the
action of triterpenes solutions and left for 3 days. To
determine whether the antiproliferative effect of
triterpenic derivatives was due to apoptosis induction,
the percentage of apoptotic cells was determined after
treatment of cells with the tested compounds. This
value was for triterpenes 57a and 57b 19.1 and
27.7 %, respectively (Table 2). The GI50 values
determined for compounds 57a and 57b were 58.8
and 57.7 lM, respectively, and they were slightly
lower in comparison to mother glycyrrhetinic acid













55  (glycyrrhetinic acid)                                                                                                 56
57a, 57b
57a: R =              ,      57b: R =                             
O O
    1. Jones reagent, acetone, rt.
2. NH2OH x HCl, pyridine, reflux
carboxylic acid anhydride, 
pyridine, DMAP, reflux
Scheme 14 The synthesis of
acylated oximes 57a, 57b
derived from glycyrrhetinic
acid (55)
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Summary
The increasing availability of oleanolic acid, betulin
and glycyrrhetinic acids allows to obtain numerous
derivatives of the above triterpenes. Among them the
remarkable attention should be paid to highly pro-
missing hydroxyimino triterpenes and the products of
their acylation.
As the literature data show, the replacement of
hydrogen atom within hydroxyimino function is one of
the most effective method of the improvement of
pharmacologicalactivityofnewtriterpenicderivatives.
New derivatives of triterpenes, of the character of
acyloximes, turned to be good antiviral agents,
particularly against HIV, HSV-1 i H7N1 influenza,
enterovirus ECHO-6, cytotoxic agents, e.g. against
MOLT-4, JurkatE6.1, CEM.CM3, BRISTOL8, U937,
DU145, PA-1, A549, L132 and HL-60 cell lines. Such
compounds were also potent hepatoprotective agents,
particularly for liver damage caused by the action of
carbon tetrachloride and they decreased the antiulcer-
ation caused by the application of indomethacin or
aspirin.
Cytotoxic and antiviral activity of the acylated
triterpenic oximes can be considered as the most
important and the most promissing type of biological
activity.
The acylation reaction of the triterpenic oximes can
be performed with the appliance of anhydrides in
refluxed pyridine in the presence of DMAP, anhy-
drides in benzene in the presence of Et3N at room
temperature, anhydrides in THF in the presence of
DMAP at room temperature, anhydrides in pyridine at
room temperature without a catalyst or activating
agent, anhydrides in methylene chloride in the
presence of Et3N and DMAP at room temperature,
acid chlorides in DMF at room temperature without a
catalyst or activating agent, acid chlorides in THF in
60 C without a catalyst or activating agent, carbox-
ylic acid in THF in the presence of DMAP and DCC at
room temperature, as well as with carboxylic acid in
dioxane in the presence of DCC at room temperature.
The most effective and the most convenient method
for the synthesis of acylated triterpenic oximes turns
out to be the last approach, as it proceeds to the highest
yields of a desired product (over 90 %) with a high
level of purity. This simple and quick manner involves
small amounts of a solvent excellently soluble in
water, that provides simple workup.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the
original author(s) and the source are credited.
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